// App-Quantinova.ai

785 : Validation of a Predictive Score of Acute Chest Syndrome (presev-2 study) in Adults

Researchers

Presenter

  • Christian Kassasseya

Principal Investigators

  • Kene Sekou

  • Tatiana Besse-Hammer

  • Ruben Nzouakou

  • Jean-Benot Arlet

  • Jean Magnang

  • Louis Affo

  • Sandrine Dautheville

  • Stphanie Ngo

  • Mehdi Khellaf

  • Dapa Aly Diallo

  • Pablo Bartolucci

Medical Centers

  • IMRB – Inserm U955 Transfusion et maladies du globule rouge (Equipe 2) Etablissement Français du Sang, APHP Henri Mondor Hospital, Créteil, France

  • Hematology, Centre de Recherche et de Lutte contre la Drepanocytose, Bamako, Mali

  • CHU-Brugmann, Brussels, Belgium

  • Barts Health NHS Trust, London, United Kingdom

  • Hopital European Georges Pompidou, Paris, France

  • Sickle Cell Referral Center, Lomé, Togo

  • APHP Louis Mourier, Colombes, France

  • Bichat Hospital, Paris, France

  • CH Saint-Denis, Saint Denis, France

  • emergency department, Henri Mondor Hospital, Assistance Publique Hopitaux de Paris, Paris XII univers, Creteil, FRA

  • Sickle cell referral center, Internal Medicine Unit, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France, CRETEIL, France

Locations

  • France

  • Mali

  • Belgium

  • United Kingdom

  • Togo

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute chest syndrome

  • Tuberculosis

  • Angina

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • Morphine

  • D-morphine

Outcome

  • N/A


Study Design

  • Observational

  • Multinational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A